ABIVAX Société Anonyme (EPA:ABVX)
94.30
+1.00 (1.07%)
At close: Dec 5, 2025
ABIVAX Société Anonyme Employees
ABIVAX Société Anonyme had 69 employees as of December 31, 2024. The number of employees increased by 8 or 13.11% compared to the previous year.
Employees
69
Change (1Y)
8
Growth (1Y)
13.11%
Revenue / Employee
€87,290
Profits / Employee
€2,831,710
Market Cap
7.13B
Employees Chart
Related Stocks
| Company Name | Employees |
|---|---|
| EssilorLuxottica Société anonyme | 153,498 |
| Sanofi | 82,878 |
| Sartorius Stedim Biotech | 9,901 |
| bioMérieux | 14,754 |
| Eurofins Scientific SE | 62,696 |
| Ipsen | 5,358 |
| Virbac | 6,365 |
| emeis Société anonyme | 83,494 |
ABIVAX Société Anonyme News
- 15 days ago - Abivax (ABVX) Shares Surge 11% on Takeover Speculation - GuruFocus
- 15 days ago - Abivax gains amid takeover speculation - Seeking Alpha
- 17 days ago - 6 Healthcare Stocks With Strong Upward Momentum - Benzinga
- 27 days ago - Abivax: Phase 3 Data Was A Home Run, Top Target For M&A In 2026 - Seeking Alpha
- 4 weeks ago - Abivax (ABVX) Reports Promising Phase 3 Trial Results for Ulcerative Colitis Treatment - GuruFocus
- 7 weeks ago - Abivax: Betting Big On The Next Inflammatory Bowel Disease Blockbuster - Seeking Alpha
- 2 months ago - Guggenheim Raises Abivax (ABVX) Price Target to $150 with Buy Rating | ABVX Stock News - GuruFocus
- 2 months ago - ABIVAX Société Anonyme (ABVX) Shareholder/Analyst Call Transcript - Seeking Alpha